Proteome Sciences Settles with Sanofi-Aventis for $15M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK proteomics services provider and reagents firm Proteome Sciences today said they have received €11 million ($15 million) from Sanofi-Aventis Deutschland to settle a claim alleging breach of certain warranties.

Proteome Sciences also announced that its revenues for the first half of 2010 more than doubled compared to a year ago while its net loss narrowed by 10 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.